Cascadia Capital Advises Seattle Reproductive Medicine in Acquisition by Pinnacle Fertility

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Seattle Reproductive Medicine (SRM), a leading fertility center headquartered in Seattle, Washington, as they join the Pinnacle Fertility (Pinnacle) network of high-performing family building centers.

For nearly two decades, SRM has helped grow families with comprehensive, expert fertility care. As a center of excellence, SRM brings a special blend of medical expertise, pioneering technology, and a large team including fourteen board-certified physicians, twelve eadvanced registered nurse practitioners, and six practice locations to the Pinnacle network.

“We were honored to work with the team at SRM, a well-recognized regional leader in fertility,” noted Kevin Cable, Cascadia Capital Managing Director. “SRM’s unique platform drove significant interest from potential partners. It was a true testament to the quality of the practice they have built.”

“We are very excited and extremely honored to bring SRM into our organization as they provide an expansive and well-regarded fertility care program to patients as well as the entire Pinnacle network,” states Andrew Mintz, CEO of Pinnacle Fertility, “By expanding our footprint in the Pacific Northwest and welcoming this distinguished team, we are deepening our commitment to leadership, collaboration, and providing the best reproductive care possible to our patients.”

Pinnacle Fertility is the nation’s fastest-growing physician-centered fertility care network, offering fertility-focused practices a platform for collaboration amongst physicians and medical leaders. Pinnacle’s patient-first approach and passion for excellence continues to set the standard in fertility care.

“We considered the opportunity to join the Pinnacle Fertility network thoroughly and felt it was the best path forward for our organization and the patients we support,” adds Dr. Paul Dudley, a leading physician at SRM. “For our patients, the care we provide remains the same high-touch experience we are known for. For our team members, we have a new opportunity to collaborate with medical thought leaders across the nation, access more resources and leading technology, and continue to grow in our field of healthcare. This all directly expands our mission to provide thoughtful, compassionate, and patient-focused fertility care, and that feels good!”

“We are thrilled to leverage the benefits of being a part of a larger network of clinics that celebrates physician leadership, fosters collaboration, offers excellence in medicine and champions success for patients across its programs,” says Dr. Nancy Klein, a founding partner and physician at SRM. “Pinnacle creates more opportunities for patients to access the best reproductive care possible and understands the meaningful work we do every day to help make dreams of building a family possible.”

Cascadia has become a key advisor to clinics and doctors interested in exploring or taking advantage of the increased transaction activity in the reproductive health sector, having advised seven fertility clients in the last twenty four months.

For more information about this transaction, please contact the Cascadia Capital deal team:

Kevin Cable
Managing Director
kcable@casdiacapital.com
(206) 696-7922

Vitaliy Marchenko
Senior Vice President
vmarchenko@cascadiacapital.com
(253) 314-3143

Or other senior members of Cascadia’s Healthcare investment banking team:

Adam Stormoen
Managing Director
astormoen@cascadiacapital.com
(612) 720-8136

Novan Le
Vice President
nle@cascadiacapital.com
(206) 436-2510

Cascadia Capital Advises Bulletin, Inc. in Acquisition by Emerald Holding, Inc.

Emerald Holding, Inc. (NYSE: EEX), the owner and organizer of NY NOW®, the wholesale market for retail where brands, buyers, and designers gather to connect and discover, today announced the acquisition of Bulletin Inc, a wholesale marketplace connecting over 3,000 independent brands with over 26,000 retailers. Cascadia Capital served as the exclusive financial advisor to Bulletin.

The acquisition of Bulletin will elevate the experience for wholesale buyers to discover a broader array of innovative brands and makers via a fusion of in-person and e-commerce offerings, creating a 24/7 platform for brands and retailers to connect and transact with each other. Further, the merger will infuse the iconic NY NOW Gift and Home Show with Bulletin’s entrepreneurial spirit, industry expertise and extensive customer base of brands and retailers. The union of these two platforms will provide small businesses access to a solution that allows them to fuel innovation and design and provide buyers with year-round inspiration and discovery.

“NY NOW is experiencing a period of transformation and revival,” said Karalynn Sprouse, EVP, Emerald. “The combination of Bulletin and NY NOW not only provides us with a dynamic platform that delivers year-round discovery and engagement, but Alana, Ali, and the Bulletin team’s thought leadership, forward-looking perspectives, and extensive network of makers, designers, influencers, and media will serve as new pathways of expression and creativity. In addition, this union reconfirms our unwavering commitment to NY NOW, especially as our 100th anniversary of being the preeminent resource for the Gift and Home industry grows near.”

“We see a massive opportunity to combine the efficiencies of our leading digital platform with the pure magic of an iconic in-person event,” says Alana Branston, Bulletin’s CEO and Co-founder. “During the pandemic, our industry lost a lot of its humanity, despite the explosion of wholesale e-commerce, and became very transaction-driven and impersonal. Because of this, it’s grown harder for brands and buyers to broker real, enduring relationships. So, we’re excited to rethink and revamp NY NOW’s format, programming, and positioning to guarantee an in-person show that puts those relationships front-and-center, underpinned by transactions and commerce at the event and year-round. It’s exactly what our customers have been asking for.”

“Alana and Ali experienced the archaic and fragmented wholesale ecosystem first-hand as a retailer and successfully created a vertically integrated and centralized technology platform connecting retailers and brands. By joining the Emerald platform, Bulletin will continue to drive significant value at greater scale,” said Teague Collins, Managing Director at Cascadia Capital.

The Bulletin marketplace supports independent brands like Piecework Puzzles, Apotheke, Golde, Kitsch and Brightland, and powers wholesale discovery and order management for innovative online-only retailers like Fast AF and social shopping app Flip, as well as a diverse pool of brick-and-mortar stores like Prelude & Dawn, Onatah General Store, the Hammer Museum in Los Angeles, Friends NYC, and thousands more.

“Cascadia understood the value of our business and their deep expertise in B2B retail/ecommerce technology allowed them to provide valuable advice and experience in navigating a complex transaction,” said Ali Kriegsman, Bulletin’s Co-founder.

The acquisition represents another successful transaction for Cascadia in the retail & commerce technology sector. Past transactions include the acquisition of Style Genome by Wayfair and Goldman Sachs’ Series C investment in Perfect Corp.

For more information about this transaction, please contact:

Teague Collins
Managing Director
tcollins@cascadiacapital.com
(206) 436-2576

Cascadia Capital Advises Green River Spirits Company in Sale to Bardstown Bourbon Company

Green River Spirits Company, a leading contract distiller and bottler of premium Green River Kentucky Straight Bourbon as well as a premier bottling partner enabled by TerrePURE technology, has been acquired by the Bardstown Bourbon Company. The transaction will forge together two leading Kentucky bourbon producers into a strong, independent spirits company with a commitment to Kentucky whiskey. Cascadia Capital served as the exclusive financial advisor to Green River Spirits.

Distilling more than 90,000 barrels for its own brands and partners, Green River Spirits is one of the oldest and largest producers of Kentucky bourbon and rye whiskey in the country. In addition to its whiskey production and bottling facility in Owensboro, Kentucky, the Company’s Charleston, South Carolina facility supports a vibrant contract business, bottling on behalf of leading partner brands.

Bardstown Bourbon Company is a leading distilled spirits producers in the country, distilling more than seven million proof gallons of whiskey annually. As a complement to its innovative contract distilling capabilities, Bardstown Bourbon Company has steadily built its own brand through its award-winning Discovery, Fusion and Collaborative Series.

The addition of Green River Spirits Company adds both the Green River brand and two production sites, positioning the combined business for continued growth in Kentucky whiskey and custom distillation. For bourbon drinkers and visitors, bringing together the historic legacy of Green River and the modern bourbon experience at Bardstown Bourbon Company provides an enticing and distinguished selection of Kentucky whiskey.

“Green River Spirits has a tremendous story, starting as a technology company serving the industry to then transforming the 10th oldest operating distillery in Kentucky into a world class distillery to serve a gap in the market” said Erik Einwalter, Managing Director at Cascadia Capital “The combination of both businesses creates the foremost contract bourbon producer with leading branded offerings across price points.”

The acquisition represents another successful transaction for Cascadia in the food & beverage sector, which has grown to be the second most active practice in industry league tables.

For more information about this transaction, please contact the Cascadia Capital deal team:

Erik Einwalter
Managing Director
eeinwalter@cascadiacapital.com
(206) 436-2538

Ryder Thomas
Vice President
thomas@cascadiacapital.com
(206) 436-2582

Or other senior members of the Cascadia Food, Beverage & Agribusiness practice:

Michael Butler
Chairman & CEO
mbutler@cascadiacapital.com
(206) 436-2530

Bryan Jaffe
Managing Director
bjaffe@cascadiacapital.com
(206) 436-2534

Scott Porter
Managing Director
sporter@cascadiacapital.com
(206) 436-2528

George Sent
Managing Director
gsent@cascadiacapital.com
(206) 436-2511

Cascadia Capital Advises The F.L. Emmert Company on Sale to Wilbur-Ellis Nutrition

Cascadia Capital, an investment bank serving middle-market clients globally, today announced that its client The F.L. Emmert Company (“Emmert” or the “Company”), a leading manufacturer and marketer of advanced nutritional solutions for the pet and livestock industries, has been acquired by Wilbur-Ellis Nutrition part of the Wilbur-Ellis companies, an international marketer, distributor and manufacturer of agricultural products, animal nutrients, specialty chemicals and ingredients. Cascadia served as the exclusive financial advisor to Emmert.

“Emmert represents the life work of our family across multiple generations,” said Carol Rod, Owner of Emmert. “While the sale of our business closes one chapter, it is also a new beginning. The idea that our science and innovation may reach a much broader audience brings our family satisfaction. We are grateful to be putting our family legacy in the hands of another highly regarded family business. Cascadia was an excellent partner in this journey.”

Emmert is a 140-year-old, family-owned company with manufacturing operations in Cincinnati, Ohio, and 35-plus employees. The Company has a proven track record in animal nutrition, delivering the right balance of brewer’s yeast, protein, vitamins, and essential amino acids to support companion animal and livestock health. As a value-added processor in the expanding U.S. and global markets, Emmert is well-known as an innovator with strong research and development capability.

“This transaction builds on our established track record of representing companies in both the ingredient sector and the companion animal and livestock end markets,” said Bryan Jaffe, Cascadia Capital Managing Director. “We are very appreciative of the trust the Rod family placed in us to find a home for their family legacy.”

“Increasingly, ingredient companies are playing a valuable role in addressing challenges and unlocking opportunities in the companion and production animal markets,” said Scott Porter, Cascadia Capital Managing Director. “Emmert’s specialized process for drying and enhancing brewer’s yeast to deliver vitality benefits and replace more costly protein content was well rewarded in this transaction. The Company brings to Wilbur-Ellis Nutrition an enviable client roster and product set that will serve a global audience in the future.”

The sale of Emmert represents another successful transaction in agribusiness and companion animal sector for Cascadia Capital and a continued demonstration of our experience in the consumables category.

For more information about this transaction, please contact the Cascadia Capital deal team:

Bryan Jaffe
Managing Director
bjaffe@cascadiacapital.com
(206) 436-2534

Scott Porter
Managing Director
sporter@cascadiacapital.com
(616) 826-9763

John Gulvezan
Vice President
jgulvezan@cascadiacapital.com
(206) 436-2549

Or other senior members of the Cascadia Food, Beverage & Agribusiness practice:

Michael Butler
Chairman & CEO
mbutler@cascadiacapital.com
(206) 436-2530

Erik Einwalter
Managing Director
einwalter@cascadiacapital.com
(206) 436-2538

George Sent
Managing Director
gsent@cascadiacapital.com
(206) 436-2511

Cascadia Capital Advises Delicious Brains’ WordPress Plugins Business in Acquisition by WP Engine

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Delicious Brains in the acquisition of its WordPress plugins business by WP Engine, a portfolio company of Silverlake.

WP Engine, one of the world’s most trusted WordPress technology companies, has acquired five popular developer-centric tools for WordPress from Delicious Brains, strengthening the company’s offerings for both traditional and headless managed WordPress. The plugins have a total installed base of approximately 4 million users and are widely adopted by WP Engine’s customers. The acquired software includes Advanced Custom Fields (ACF), WP Migrate, WP Offload Media, WP Offload SES, and Better Search Replace.

Delicious Brains Inc was established in 2012 by Founder & CEO Brad Touesnard with the humble goal of building a profitable software company, starting with a pro version of the free WP Migrate plugin. Fast forward to the present and the business has grown to five products and a team of over 20 people across five continents.

Mr. Touesnard wasn’t originally contemplating an exit, until he considered selling the plugin side of the business and maintaining SpinupWP, an app that serves as a cloud-based server control panel. This was a highly attractive option for a serial entrepreneur that wanted to lean into the software company he’d built and loved.

“Cascadia was wonderful to work with from the upfront negotiations, through due diligence and in the final stages,” said Mr.Touesnard. “I would highly recommend Cascadia to entrepreneurs considering options for a future exit of their business.”

“It was a pleasure to work with Brad on this transaction,” added Cascadia Capital Managing Director Matt Riendeau. “I’m glad he will be able to focus his time, energy and attention on SpinupWP. The prospects for that plugin are very bright.”

For more information about this transaction, please contact the Cascadia Capital deal lead:

Matt Riendeau
Managing Director
mriendeau@cascadiacapital.com
(206) 436-2568

 

Cascadia Capital Advises 626 Imaging Services in Acquisition by Peak Rock Capital

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to 626 Holdings Equity, LLC (“626” or the “Company”), a leading provider of imaging equipment maintenance services, to Peak Rock Capital (“Peak Rock”), a middle market private equity firm.

Founded in 2012, 626 is a leading provider of imaging equipment services, focused on providing responsive service to outpatient imaging centers, hospitals, and other Independent Service Organizations. 626 is one of the fastest growing third party imaging servicing companies in the U.S. and provides expertise in virtually all medical imaging equipment manufacturers and modalities. Headquartered in Delray Beach, Florida, the Company has built an excellent reputation in the industry for its high-quality, rapid service and national footprint.

“I am incredibly proud of the organization that our team has built, and how our technical expertise and excellent service levels have allowed us to achieve industry-leading growth. I’m excited to add Peak Rock as a partner, as their resources and expertise will support us in further expanding our imaging services platform,”” said Phil Revien, co-founder and Chief Executive Officer of 626. “We are grateful to Cascadia for being a trusted advisor in the formation of this partnership. Their industry expertise and knowledge of the investor landscape proved immensely valuable in this process.”

“This is an excellent outcome for a great client,” added Adam Stormoen, Cascadia Capital Managing Director. “We have a deep focus in the medical equipment service sector and are supporting several additional clients in the space.”

For more information about this transaction, please contact the Cascadia Capital deal team:

Adam Stormoen
Managing Director
astormoen@cascadiacapital.com
(612) 260-8060

Vitaliy Marchenko
Senior Vice President
vmarchenko@cascadiacapital.com
(253) 314-3143

Other senior members of the Cascadia Healthcare team include:

Kevin Cable
Managing Director
kcable@cascadiacapital.com
(206) 696-7922

Novan Le
Vice President
nle@cascadiacapital.com
(206) 436-2510

Michael Madden
Vice President
mmadden@cascadiacapital.com
(206) 436-2588

Cascadia Capital Represents Ardian and MidOcean Partners in Important Ingredients Transaction

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the financial advisor to Ardian and MidOcean Partners, two leading private equity firms, and their portfolio company Florida Food Products (“FFP”) in the acquisition of TBev Natural Ingredients.

FFP identified the opportunity to partner with TBev as the company’s extraction technology is compatible with FFP’s focus on beverage development and innovation.

“We’re proud to be associated with this important transaction in the ingredients sector,” noted George Sent, Cascadia Capital Managing Director. “This continues our focus on playing a meaningful role in the clean label movement within the Food space.”

The acquisition represents another successful transaction for Cascadia in the ingredients sector. Past transactions include Pacific Farms, FruitSmart, More than Gourmet, and Firestone Pacific Foods.

For more information about this transaction, please contact the Cascadia Capital the deal team lead:

George G. Sent Jr.
Managing Director
gsent@cascadiacapital.com
(206) 436-2511

Or other senior members of the Food, Beverage & Agribusiness team at Cascadia:

Michael Butler
Chairman & CEO
mbutler@cascadiacapital.com
(206) 436-2530

Erik Einwalter
Managing Director
eeinwalter@cascadiacapital.com
(206) 436-2538

Bryan Jaffe
Managing Director
bjaffe@cascadiacapital.com
(206) 436-2534

Scott Porter
Managing Director
sporter@cascadiacapital.com
(206) 436-2528

Cascadia Capital Advises Shipfusion in Receiving a Growth Equity Investment from Kayne Anderson Capital Advisors ​​​​​​​

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Shipfusion, a leading provider of technology and fulfillment solutions for premium eCommerce brands, in receiving a growth equity investment from Kayne Anderson Capital Advisors, a private equity fund targeting investments in emerging growth companies within the software and logistics sectors.

Cascadia strategically positioned and effectively articulated the Company’s differentiated software and fulfillment capabilities, broadly diversified enterprise client base, and scalable platform, all of which support its path to significant growth within the eCommerce fulfillment market.​​​​​​​ By highlighting Shipfusion’s custom-built, proprietary software and extensive warehouse network that provides fulfillment services to premier eCommerce brands across the U.S., Cascadia achieved an outstanding outcome for its investors, owners, and employees. Cascadia’s experience in the software, logistics, and supply chain technology sectors played a crucial role in positioning the Company in a highly competitive sector landscape.

Based in Chicago and founded in 2014, Shipfusion utilizes custom-built, proprietary software with an application programming interface, full warehouse management system and automation controls to provide superior solutions to its customers. The Company’s capabilities include complex integration, innovative picking strategies, temperature-controlled facilities, advanced reporting tools, and end-to-end lot tracking that offer market leading B2B fulfillment, inventory management and analytics, and optimized shipping rates. In addition, Shipfusion provides customers with class leading, technology enabled support services that are differentiated in the space and support its unique value proposition.

Kayne Anderson Capital Advisors is a Los Angeles-based private equity firm that specializes in growth equity investments across a broad range of industries including supply chain and logistics, media and telecom, business process automation, financial technology, healthcare, and security compliance. The firm recognized Shipfusion’s industry growth potential, differentiated software capabilities, and top-flight management team that established the Company as a great fit for its evolving technology enabled logistics thesis.

“Cascadia provided excellent strategic advice to us throughout our capital raise process. Specifically, their expertise in both technology and logistics provided the ideal perspectives to secure a strong capital transaction with a leading growth equity firm,” said Shipfusion CEO and Co-Founder Brandon Luft.

”Shipfusion sits at the intersection of eCommerce, technology enabled services and software led-fulfillment. As the supply chain evolves, both in response to today’s challenges and tomorrow’s opportunities, the Company is ideally positioned to benefit from these tailwinds as a market leading and differentiated platform for growth. Brandon and the team have found the perfect partner in Kayne Anderson and we look forward to their accelerated progress together,” said Firdaus Pohowalla, Managing Director and Head of Supply Chain Technology at Cascadia Capital.

“As a bootstrapped business, Shipfusion has focused on developing their proprietary software and strategic warehouse network and with the capital investment is now poised to drive significant growth in the market,” added Teague Collins, Managing Director and Co-Head of Software.

The transaction represents another successful transaction for Cascadia in its market leading transportation, logistics and supply chain technology practice focused on software, automation and services. Recent transactions include StyleGenome’s acquisition by Wayfair, FragilePak’s acquisition by Greenbriar Equity, Perfect Corp.’s Series C investment from Goldman Sachs, and the sale of Cory to J.B. Hunt Transportation Services.

For more information about this transaction, please contact the Cascadia Capital deal team:

Teague Collins
Managing Director
tcollins@cascadiacapital.com
(206) 436-2576

Firdaus Pohowalla
Managing Director
fpohowalla@cascadiacapital.com
(206) 436-2578
​​​​​​

Cascadia Capital Advises Tegria in Completing a Major Investment in Cloud21

Cascadia Capital, an investment bank serving middle market clients globally, is pleased to announce it acted as the exclusive financial advisor to Tegria, an innovative company launched by Providence to provide next-generation technologies and services to the healthcare sector, in completing a major investment in Cloud21, a digital health consultancy based in the UK.

The investment from Tegria will allow the companies to combine Cloud21’s deep and longstanding experience of working with the NHS, with Tegria’s extensive international, end-to-end digital strategy and support services across healthcare.

Cloud21 will leverage Tegria’s global team of more than 3,500 clinicians, technologists, scientists, and strategists, to support healthcare systems and organizations, as they plan to implement government’s latest digital priorities and targets, and improve patient experiences and outcomes through technology.

Together the two organizations, who both focus solely on healthcare infrastructure, have unmatched experience in strategic transformation, enablement, and deployment, as well as proven credibility in the implementation and optimization of every single major EPR system.

“This investment is enabling Cloud21 to provide a unique offering to the health and social care sector and helping providers level-up or scale-up their digital abilities at local, regional, and national levels in the UK,” said Dr. Tony Corkett, CEO of Cloud21. “For technology to deliver benefits and enable staff to provide care effectively, we need to match any technology investment with equal investments in implementation and change management – taking our people on the journey and making the new processes work in the real world. Working with Tegria enhances our capabilities to deliver this at scale, throughout the entire digital journey.”

The companies have already started working together to help healthcare organizations accelerate their digital maturity, and discussions with healthcare leaders across the UK are at an advanced stage.

Tegria draws on and shares the lessons learned from working with 500+ healthcare organizations across the globe, to help them tackle the three cornerstones of any successful EPR program: the people, the processes, and the technology. Tegria’s founder, Providence, is a leading not-for-profit integrated care organization, and one of the largest health systems in the US, providing Tegria with unique insights on large scale digital transformation.

“As the NHS moves towards establishing integrated care boards and places and addresses the operational and cultural challenges of digital transformation, our end-to-end experience means we are uniquely placed to share decades of learning around optimizing digital and data,” added Justin Jozwik, Managing Director of Tegria.

“This, combined with Cloud21’s strong footprint as a trusted partner to the NHS and unmatched understanding of the varying levels of need across the sector, gives us an unprecedented opportunity to make meaningful change at pace and scale.”

This is the ninth transactions that Cascadia has supported for Tegria and Providence, having previously provided buy-side advisory services for Tegria and Providence acquisitions, including KenSci, Colburn Hill, Cumberland, Acclara Solutions, MediRevv, Bluetree and Navin, Haffty & Associates.

“Tegria’s international expansion into Europe is a major milestone for the organization,” said Kevin Cable, Co-Founder and Managing Director at Cascadia. “Our firm is proud to represent Tegria and Providence through this growth journey in creating a better healthcare infrastructure on a global scale.”

For more information about this transaction please contact:
​​​​​​​
Kevin Cable
Managing Director
kcable@cascadiacapital.com
(206) 696-7922

Novan Le
Vice President
nle@cascadiacapital.com
(206) 436-2510

Other senior members of the Cascadia Healthcare team include:

Adam Stormoen
Managing Director
astormoen@cascadiacapital.com
(612) 260-8060

Vitaliy Marchenko
Senior Vice President
vmarchenko@cascadiacapital.com
(253) 314-3143

Michael Madden
Vice President
mmadden@cascadiacapital.com
(206) 436-2588

Cascadia Capital Advises Psychiatric Centers at San Diego on its Acquisition by Mindpath Health

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Psychiatric Centers at San Diego (“PCSD”) on its sale to Mindpath Health, a leading independent U.S. provider of outpatient behavioral health services.

PCSD is a leading provider of outpatient behavioral health services with over 124 providers working across eight locations in Southern California. The group has operated in Southern California since 1972 and offers a multidisciplinary clinical approach utilizing state of the art treatment modalities such as psychopharmacology, individual, couples, family and group therapy.

Mindpath Health is a leading independent provider of outpatient behavioral health services with a national footprint covering patients coast to coast. Mindpath Health offers patients a range of treatments and modalities, including psychiatry, psychotherapy, psychological testing and transcranial magnetic stimulation to improve patient outcomes.

“The combination allows both companies to further promote their collective mission of increasing patient accessibility to high-quality behavioral healthcare. This partnership is truly a win-win,” said Kevin Cable, Managing Director in Cascadia’s Healthcare Group.

“The behavioral health industry has continued to change at a rapid pace and the shareholders saw a compelling opportunity to join a preeminent platform in the space,” added Chris Morache, CEO of PCSD. “Cascadia did a great job positioning PCSD to garner the attention of the highest quality behavioral health providers. We greatly look forward to partnering with Mindpath Health to further promote our collective vision of providing greater access to high quality behavioral healthcare.”

The acquisition represents another successful transaction for Cascadia in the healthcare services sector. Recent client transactions within the healthcare services sector include the sales of Utah Fertility Center, Nevada Center for Reproductive Medicine, Nevada Fertility Center and Pacific Northwest Fertility to Ivy Fertility, and the sales of Reproductive Partners Medical Group and San Diego Fertility Center to InTandem Capital.

For more information about this transaction please contact:

Kevin Cable
Managing Director
kcable@cascadiacapital.com
(206) 696-7922

Other senior members of the Cascadia Healthcare team include:

Adam Stormoen
Managing Director
astormoen@cascadiacapital.com
(612) 260-8060

Vitaliy Marchenko
Senior Vice President
vmarchenko@cascadiacapital.com
(253) 314-3143

Novan Le
Vice President
nle@cascadiacapital.com
(206) 436-2510

Michael Madden
Vice President
mmadden@cascadiacapital.com
(206) 436-2588

Trust. Experience. Independence. Results.
Close

Access Resource

Please complete the form below to access this resource.

  • This field is for validation purposes and should be left unchanged.